NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non Hodgkin Lymphoma & Combined With Daratumumab for Multiple Myeloma

Conditions:   Multiple Myeloma;   Non Hodgkin Lymphoma Interventions:   Drug: NKTR-255;   Drug: Daratumumab Sponsor:   Nektar Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials